Early Surgery Versus 3 Days Non-surgical Management in Acute Small Bowel Obstruction (SURGI-BOW)
Launched by UNIVERSITY HOSPITAL, ANGERS · Sep 26, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The SURGI-BOW clinical trial is studying the best way to treat patients with uncomplicated acute small bowel obstruction (aSBO). Currently, guidelines suggest trying non-surgical treatments for 72 hours before considering surgery. However, this approach only works for 60 to 70% of patients, meaning some still need surgery after a few days. This trial is exploring whether performing surgery earlier, within 24 hours, could lead to better outcomes by reducing complications and hospital time. Researchers believe that advancements in surgical techniques, especially laparoscopic surgery (a less invasive method), may make early surgery safer and more effective.
To participate in this trial, you must be an adult admitted for small bowel obstruction confirmed by a CT scan, and you need to provide informed consent. Unfortunately, those with urgent surgery needs, such as ischemia (lack of blood flow), or certain other conditions, are not eligible. If you join the trial, you can expect to be part of a study that may help determine the best treatment approach for aSBO, potentially improving care for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Admission for acute intestinal obstruction of the small intestine on adhesion or bridle
- • Confirmation of the aSBO by a scanner
- • Adult patient
- • Beneficiary of a social security scheme
- • Having signed an informed consent
- Exclusion Criteria:
- • Indication for urgent surgery (small intestine ischemia, intestinal pain, defence, hemodynamic shock, etc.)
- • Pregnancy or breastfeeding
- • Poor understanding of the French language
- • Person deprived of liberty by judicial or administrative decision
- • Person undergoing psychiatric treatment under duress
- • Person subject to a legal protection measure
- • Person unable to express consent
About University Hospital, Angers
The University Hospital of Angers is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital leverages its multidisciplinary expertise and state-of-the-art facilities to investigate new therapeutic approaches and improve patient outcomes. Committed to excellence in patient care and medical education, the University Hospital of Angers collaborates with a network of researchers and healthcare professionals to facilitate groundbreaking studies across various medical fields, ensuring rigorous adherence to ethical standards and regulatory compliance. Through its clinical trial initiatives, the institution aims to contribute significantly to the advancement of medical knowledge and the development of effective treatments.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Angers, , France
Amiens, , France
Strasbourg, , France
Nice, , France
Montpellier, , France
Nantes, , France
Rennes, , France
Brest, , France
Pierre Bénite, , France
Amiens, , France
Angers, , France
Brest, , France
Chambray Lès Tours, , France
Château Gontier, , France
Dijon, , France
Grenoble, , France
Montpellier, , France
Nantes, , France
Nice, , France
Pierre Bénite, , France
Rennes, , France
Roche Sur Yon, , France
Strasbourg, , France
Chambray Lès Tours, , France
Château Gontier, , France
Dijon, , France
Grenoble, , France
Roche Sur Yon, , France
Patients applied
Trial Officials
Cécile Jaglin-Grimonprez
Study Director
University hospital of Angers
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported